There’s no need to control PFAS as a class, industry scientists say


The number of commercial per- and polyfluoroalkyl substances (PFAS) that need screening for possible regulation number in the hundreds, not thousands, industrial chemists say (Integr. Environ. Assess. Manage. 2021, DOI: 10.1002/ieam.4450).

Their analysis counters a policy proposal in the European Union that would restrict production and use of most PFAS—persistent synthetic chemicals designed to resist degradation—as a single class. Exposure to PFAS that are metabolically active is linked to cancer, immune system problems, developmental problems, and other health effects.

“It’s not scientifically accurate or appropriate to base regulation on a false premise, which is what some authorities are proposing to do by saying that the number of PFAS is so high that it’s impossible to distinguish among them,” says lead author Robert Buck, a technical fellow at Chemours.

In the study, Buck’s team examined the 4,730 PFAS listed in a 2018 report from the Organisation for Economic Co-operation and Development (OECD). The researchers say that the OECD report included PFAS that were phased out of production, never commercialized, or made in small quantities, such as less than 1 kg, for research purposes. Such chemicals aren’t candidates for regulation, they say.

The American Chemistry Council (ACC), the largest association of US chemical manufacturers, assisted the study. The ACC hired a consulting firm to collect data from PFAS makers AGC Chemicals Americas, Chemours, and Daikin; aggregate the information; and protect trade secrets.

The authors, one from each of the three companies along with an independent fluorochemicals consultant, then analyzed the data. They determined that 256 of the PFAS in the OECD report are “commercially relevant,” meaning they are present in products offered for sale, used to make those products, or contain impurities or degradation products such as metabolites.

If PFAS from other manufacturers were analyzed similarly, the total number of commercially relevant substances would likely rise above 256 but fall far below the OECD’s number, Buck tells C&EN.

And several hundred PFAS, “in our opinion, would not present an unmanageable situation for regulatory authorities,” says Jay West, executive director of ACC’s Performance Fluoropolymer Partnership. The three participating companies are members of the partnership.

Read More

Chemical & Engineering News, 19 May 2021